SBN 0.00% 0.0¢ sun biomedical limited

The market is very large, and growing. Hard to gauge the value...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,234 Posts.
    lightbulb Created with Sketch. 69
    The market is very large, and growing. Hard to gauge the value either in Australia or worldwide given the shift from urine to drug testing.

    There are various similar tests out there already so it will be interesting to see what separates Oraline from the others.

    Apparently Oraline was once the best out there but had certain problems which have now been fixed (see previous announcements). Seems the company has been working on making it the best once again.

    In terms of revenues, these units would not be expensive to buy, but the volumes of units needed in use would be very high. Think how convenient a saliva test would be to workplaces. The units are probably very cheap to manufacture as the real cost behind the product lies in the intellectual property and the millions spent in R&D expenditure over the years. It could be time to reap the rewards of that.
 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.